Home Compliance Pharmaceutical Manufacturer Pays $3.5 Million for Producing “Adulterated Drugs” and Connected FCA... ComplianceDOJFCANews Pharmaceutical Manufacturer Pays $3.5 Million for Producing “Adulterated Drugs” and Connected FCA Violation March 7, 2024 2 Share FacebookLinkedinTwitter Aleksandra Gigowska | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance DOJ Implementation and Enforcement Plans for the Sensitive Data Executive Order—What It Means for Organizations Compliance Whistleblower Network News: DOJ Must Listen to the Whistleblower Community in Developing Whistleblower Program Compliance You Can Use Whatever Monitor, But Be Reasonable on What Is Necessary